http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Effects of β-Lapachone on Gastric Secretion
Yun-Bae Kim, Dongsun Park, In Geun Cho, Yun-Hui Yang, Jangbeen Kyung, Dajeong Kim, Ehn-Kyoung Choi, Tae Hwan Kwak3, Sang Ku Yoo 충북대학교 동물의학연구소 2011 Journal of Biomedical and Translational Research Vol.12 No.3
The effects of β-lapachone on gastric secretion were investigated. The pylorus of male Sprague-Dawley rats was ligated and intraduodenally injected with β-lapachone, and the volume, pH, free HCl, and total acidity of gastric fluid were measured 6 hours after the operation. Treatment with β-lapachone resulted in dose-dependent inhibition of gastric secretion Gastric fluid was reduced to 42.9% of control level by 100 mg/kg of β-lapachone, leading to an increase of pH to 6.70 from 1.85 in the control group. In parallel with the increase of pH, at this dosage, free HCl and total acidity decreased to 16.7% and 12.0%, respectively, of control levels. β-Lapachone exhibited ED50 values of 72, 46, and 47 mg/kg for inhibition of gastric volume, free HCl, and total acidity, respectively, implying a superior efficacy on gastric acid to volume. In comparison, pantoprazole (30 mg/kg) reduced the volume, free HCl and total acidity of gastric fluid to 53.0%, 26.0%, and 25.0%, respectively, of control levels, resulting in an increase in pH to 6.36. In the current study, it was confirmed that β-lapachone at an appropriate dose (100 mg/kg) exerted a higher inhibitory effect on gastric secretion than pantoprazole (30 mg/kg), a well-known proton-pump inhibitor. Therefore, it is suggested that β-lapachone could be a candidate compound for prevention or treatment of gastric ulcers induced by diverse psychological and physical stimuli.
보건의료 R&D 연구성과 활용·확산을 위한 특허맵 분석 및 활용방안 연구
전수환(Su-Hwan Cheon),이경민(Kyung-Min Lee),김미경(Mi-Kyoung Kim),제영태(Young-Tae Je),신상훈(Sang-Hun Shin),김명환(Myung-Hwan Kim),김동석(Dong-Seok Kim),박성호(Seong-Ho Park),김기택(Gi-Tae Kim),곽정애(Jung-ae Kwak),전혜경(Hye-Kyoung 한국생물공학회 2013 KSBB Journal Vol.28 No.6
Translational research (TR) as high quality research can accelerate collaboration strongly between biotechnology-based researchers and clinical-research experts for overcoming diseases. TR facilitates basic science translated to clinical efficacy and effectiveness from bench (basic science) to bedside (clinical practice) for the enhancement of human health. Disease-oriented TR programs were defined as unilateral, bilateral and multilateral TR in this patent performance analysis. Patent performance was measured in a R&D project on Health and Medical Technology to enhance the productivity of R&D investment on disease-oriented TR in Health Technology (HT). Patent Map (PM) analysis and Bibliometrics were conducted to collect information for the assessment of research patents of TR programs. Futhermore, PIAS (Patent Information Analysis System) and Thinklear programs were applied for quantitative and qualitative analysis successfully. These indicate that multi-dimensional analysis of patent performance for disease-oriented TR could promote the connection of R&D-IP (Research and Development-Intellectural Property) and R&BD (Research and Business Development) supporting system significantly.
Antimicrobial Activities of LB20304a,a New Quinolone Antibiotic
Kwak, Jin Hwan,Lee, Kyung Won,Kim, In Chull,Kim, Mu Yong,Paek, Kyoung Sook,Kwon, Oh Hun 한국응용약물학회 1996 Biomolecules & Therapeutics(구 응용약물학회지) Vol.4 No.4
In vitro activities of LB20304a were compared with those of grepafloxacin (OPC-17116), Q-35, ciprofloxacin, and sparfloxacin against 380 clinical isolates collected from general hospitals in 1996. LB 20304a was the most active agent against gram-positive strains including staphylococci, streptococci and enterococci. LB20304a was also very active against gram-negative bacteria and its activity was comparable to that of ciprofloxacin but better than those of grepafloxacin, Q-35 and sparfloxacin. The therapeutic effect of LB20304a was superior to those of sparfloxacin and ciprofloxacin against systemic infection by methicillin-resistant Staphylococcus aureus K283 (MRSA) in neutropenic mice. Against urinary tract infection induced by Escherichia coli 851E in mice, LB20304a was more active than sparfloxacin and ciprofloxacin. However, LB 20304a was slightly less active than that of ciprofloxacin against urinary tract infection by Pseudomonas aeruginosa 1912E, but better than that of sparfloxacin.
Azoloquinoxaline類의 간편한 合成에 관한 硏究 : 第1報
郭美玉,南順花,金恩慶,金眞姬,韓盛旭,李萬佶,朴義煥,金浩植 고신대학교 자연과학연구소 1993 고신대학교 자연과학연구소 논문집 Vol.3 No.-
The reaction of 2, 6-dichoroquinoxaline with m-chloroperbenzoic acid gave 2, 6-dichloroquinoxaline 4-oxide, whose reaction with sodium azide provided 7-chlorotetrazolo[1, 5-a]quinoxaline 5-oxide and not the isomeric azide. The structures of the synthesized compounds were confirmed on the basis of IR, ¹H-NMR, elemental analysis and mass spectral data.
Factors Affecting in Vitro Activity of LB20304, a New Flu-oroquinolone
Paek, Kyoung-Sook,Ahn, Mi-Jeong,Kim, Mu-Yong,Kim, In-Chull,Kwak, Jin-Hwan The Pharmaceutical Society of Korea 1996 Archives of Pharmacal Research Vol.19 No.2
LB20304 is a novel fluoroquinolone that exhibits a potent broad spectrum antibacterial activity against both gram-positve and gram-negative bacteria. The MICs (Minimal Inhibitory Concentration) of LB20304 were determined against both gram-positve and gram-negative bacteria under various conditions including several media, pHs, and inoculum concentrations. The in vitro activity of LB20304 was not significantly affected by the changes in testing conditions such as components of media and inoculum concentrations, but it was slightly reduced by acid condition. The MICs and MBCs (Minimal Bactericidal Concentration) of LB20304 against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa were hardly affected by the presence of 50 % human serum, mouse serum, guinea pig serum or horse serum, and the MBCs were equal to or at most four-times higher than the MiCs. The activities of LB20304 were decreased by the presence of high concentraion of $Mg^{++}$ or human urine (pH, 5.5) in the test media. The frequencies of mutants resistant to LB20304 were similar to or lower than those found in ciprofloxacin and sparfloxacin.
싱글코어 ECU에서 멀티코어 ECU로의 효율적 전환을 위한 공유 자원 보호
곽환주(Hwan-Joo Kwak),이태경(Tae-Kyoung Lee),차현준(Hyun-Jun Cha),박재학(Jae-Hak Park),김종찬(Jong-Chan Kim) 대한전자공학회 2016 대한전자공학회 학술대회 Vol.2016 No.6
This paper shows the migration process of engine management system from singlecore ECU to multicore ECU. When doing that, factors such as inter-core shared resource protection and runnable sequencing should be considered. With this motivation, an efficient spinlock strategy and task splitting mechanisms are presented. Our methods are evaluated using an actual engine management system developed by Hyundai Autron, which shows a successful migration result in terms of both efficiency and stability.